Gastrointestinal involvement in systemic sclerosis: diagnosis and management

Area of Science:

• Gastroenterology
• Rheumatology
• Internal Medicine

Background:

• Systemic sclerosis (SSc) frequently causes gastrointestinal (GI) dysmotility, a complex condition challenging to diagnose and manage.
• GI manifestations in SSc are diverse, impacting patient quality of life and requiring tailored therapeutic approaches.

Purpose of the Study:

• To provide an updated review of diagnostic insights and therapeutic strategies for SSc-related GI dysmotility.
• To highlight recent advancements in both novel and existing treatments for GI dysmotility syndromes.

Main Methods:

• Review of recent scientific literature published within the last two years.
• Analysis of studies focusing on diagnostic tools and therapeutic interventions for SSc-associated GI dysmotility.

Main Results:

• Emerging diagnostic insights aid in identifying patterns of GI dysmotility in SSc.
• Several pharmacological agents (e.g., prucalopride, linaclotide) and combination therapies are under investigation.
• Non-pharmacological interventions like dietary modifications and electroacupuncture show potential but require further research.

Conclusions:

• Progress has been made in understanding and managing SSc-GI dysmotility.
• Objective diagnostic methods are crucial for targeted therapy selection.
• Ongoing research into new and existing therapies offers hope for improved patient outcomes and quality of life.